Leerink Partners Maintains Market Perform on Hims & Hers Health, Raises Price Target to $25

Benzinga Newsdesk www.benzinga.com Positive 82.3%

Neg 0% Neu 0% Pos 82.3%

Leerink Partners analyst Michael Cherny maintains Hims & Hers Health (NYSE:HIMS) with a Market Perform and raises the price target from $17.5 to $25.